IPSEN PHARMACEUTICALS, INC.
IPSEN PHARMACEUTICALS, INC.
Industry:
Biotechnology Health Care
Founded:
2005-01-01
Address:
Morristown, New Jersey, United States
Country:
United States
Status:
Active
Contact:
973-867-5555
Similar Organizations
Oclassen Pharmaceuticals
Oclassen Pharmaceuticals, Inc. was acquired by Watson Pharmaceuticals Inc.
More informations about "Ipsen Pharmaceuticals, Inc."
About Ipsen | Pioneering Biopharmaceutical Company - Global
Learn about Ipsen, a global pharma company that aims to prolong patients’ lives, improve health outcomes and create a positive impact for patients and society. ... We do this by striving to …See details»
Ipsen - Wikipedia
Ipsen is a French biopharmaceutical company headquartered in Paris, France, with a focus on drug development and commercialization in three therapeutic areas: oncology, rare diseases …See details»
Who We Are - ipsen.com
We are a global, mid-size pharmaceutical company focusing on areas of high unmet medical need. Focus. Together. For patients and society. ABOUT IPSEN ... Functioning independently …See details»
Ipsen - The Org
Ipsen is a global specialty-driven biopharmaceutical group focused on innovation and Specialty Care. It develops and commercializes innovative medicines in three key therapeutic areas - Oncology, Neuroscience and Rare Disease. ...See details»
Ipsen Pharmaceuticals, Inc. - Crunchbase Company Profile
Ipsen Pharmaceuticals, Inc. delivered strong financial results in the first half of 2024, leading to an upgrade in its full-year guidance. The company also secured ex-US rights to a pediatric cancer …See details»
Ipsen (Pharmaceuticals) - PitchBook
Ipsen (Pharmaceuticals) General Information Description. Ipsen is a global biotechnology company headquartered in France that develops and commercializes medicines across three …See details»
Ipsen - Crunchbase Company Profile & Funding
Ipsen is a global specialty-driven biopharmaceutical company focused on innovation and specialty care. ... Pharmaceutical . Product Research . Headquarters Regions European Union (EU), …See details»
Ipsen: Shareholders Board Members Managers and Company …
4 days ago Ipsen specialises in the research, development, manufacture and marketing of specialty medicines. Net sales by therapeutic area break down as follows: - oncology (75.2%); …See details»
Ipsen: who we are - United States
Learn about Ipsen, a global pharma company that aims to prolong patients’ lives, improve health outcomes and create a positive impact for patients and society. ... We do this by striving to discover, innovate and bring to market …See details»
Ipsen - LinkedIn
Ipsen | 245,194 followers on LinkedIn. We are a global biopharmaceutical company with a focus on bringing transformative medicines to patients in three therapeutic areas: Oncology, Rare …See details»
Ipsen Biopharmaceuticals - MassBio
Ipsen is a global specialty-driven pharmaceutical group with total sales exceeding €1.4 billion in 2015. Ipsen sells more than 20 drugs in more than 115 countries, with a direct commercial …See details»
Ipsen | Company Overview & News - Forbes
Ipsen SA manufactures pharmaceutical products for oncology, neuroscience and rare diseases. It operates through following segments: Specialty Care andSee details»
Ipsen: Accelerating profitable growth in pharma
Dec 9, 2024 Part One: Ipsen, a global pharmaceutical firm headquartered in France, was facing significant challenges, including regulatory setbacks and fierce competition, when David Loew …See details»
Ipsen – improving patient health outcomes - Ipsen Canada
Ipsen is dedicated to safeguarding and preserving our planet. The Generation Ipsen ESG sustainability strategy lays out ambitious goals for the company in each of our four pillars: …See details»
Member profile: Ipsen Biopharm Ltd | BIA - bioindustry.org
Neuroscience is advancing at an unprecedented rate and Ipsen is at the forefront of this transformation. Ipsen also has a well-established Consumer Healthcare business. With total …See details»
Ipsen Company Profile - Office Locations, Competitors, Revenue
Oct 29, 2024 Ipsen is a global specialty-driven biotechnological group with total sales exceeding €1.2 billion in 2014 in more than 115 countries, with a direct commercial presence in 30 …See details»
Ipsen - Funding, Financials, Valuation & Investors - Crunchbase
Ipsen 's most notable exits include Pyxis Oncology, Xilio Therapeutics, and Rhythm Pharmaceuticals. Ipsen has acquired 11 organizations. Their most recent acquisition was …See details»
Ipsen – improving patient health outcomes - United States
Ipsen offers a multitude of exciting opportunities for talented and motivated people in careers ranging from medical and clinical research to sales, marketing, finance, IT, HR and legal …See details»
Pharma taps Holland & Knight ahead of orphan drug tax fight
4 hours ago — Vertex Pharmaceuticals, Ipsen Biopharmaceuticals, ... — Victoria Gemme is now director of policy and regulatory affairs at the National Organization for Rare Disorders.See details»
Research & Development at Ipsen | Pioneering Biopharmaceutical …
Discover Ipsen's pioneering efforts in biopharmaceutical research and development. Committed to advancing science for better patient care. ... We are an organization deeply rooted in science; …See details»